Company Filing History:
Years Active: 2007-2011
Title: Innovations by Yasser Nashed in Peptidyl Prodrugs
Introduction
Yasser Nashed is an accomplished inventor based in Thousand Oaks, California, known for his contributions to the field of pharmaceuticals. With a total of two patents to his name, he has made significant strides in developing innovative methods for drug delivery systems.
Latest Patents
Yasser's latest patents focus on the creation of peptidyl prodrugs that resist P-glycoprotein mediated drug efflux. One patent describes a method of treating patients with conditions involving bioactive agents that are substrates for the P-glycoprotein transporter. This method includes administering a specific compound formula, which allows for more effective treatment outcomes. The second patent presents derivatives of bioactive agents, specifically dipeptides, tripeptides, and tetrapeptides, which are designed for targeted delivery through nutrient or peptide transporters. These innovative approaches aim to enhance the effectiveness of various drugs while minimizing potential side effects.
Career Highlights
Yasser Nashed is associated with the University of Missouri, where he applies his research expertise to advance pharmaceutical sciences. His academic and research endeavors have contributed to the growing field of drug delivery mechanisms, focusing on improving patient treatment options.
Collaborations
Throughout his career, Yasser has collaborated with several noteworthy coworkers, including Ashim K Mitra and Soumyajit Majumdar. These collaborations have fostered a multidisciplinary approach to research and innovation, further advancing the impact of their work in the pharmaceutical industry.
Conclusion
Yasser Nashed stands out as a notable inventor in the realm of pharmaceutical innovations. His focus on developing methods that resist drug efflux through the P-glycoprotein transporter has the potential to significantly improve treatment outcomes for patients. His work at the University of Missouri, alongside esteemed colleagues, continues to contribute to advancing the field, exemplifying the spirit of innovation in the healthcare sector.